An article summarizing inventor Robert Kearns’ epic battle against the automobile industry is this year’s most read IP CloseUp post with more than 21,000 visits.
An article summarizing inventor Robert Kearns’ epic battle against the automobile industry is this year’s most read IP CloseUp post with more than 21,000 visits.
Donald J. Trump, Jr.’s editorial in the The Daily Caller in 2012, a conservative leaning publication that generates more than 16 million monthly visits, indicates that
There are abundant statistics on the cost of counterfeit goods, copyright infringement and even the negative impact of patent “trolls,” but nothing on the estimated
A unique public-private partnership provides medical research centers and the patents they generate with a more efficient and rewarding path toward commercialization. Bridge Medicines is a drug discovery
Many law firms still seek to participate in the outcome of clients’ patent litigation, but few are willing to share the cost of obtaining and
The Electronic Frontier Foundation (EFF) is attempting to paint a scarlet letter on universities with public funding who benefit from sharing discoveries with those best-equipped
Tens of thousands of recording artists and musicians in Germany will be receiving payment for their content under the terms of agreement struck last week
The size of businesses sued most frequently for patent infringement in 2016 were significantly larger than in 2015, when five little-known patent holders were among
IP Dealmakers Forum is one of the more anticipated IP events of the year, especially for those engaged in patent licensing, sales, and M&A transactions.
The $85.4 billion buyout of Time Warner Corporation (TWC) by AT&T, if it goes through, is a good omen for the value of content providers,
Measures of a brand’s power can differ dramatically, depending on performance criteria. A new success index believes that in an increasingly connected world, traditional measures
Public IP licensing companies (PIPCOs) are very much alive and some company shares are doing surprisingly well, despite increased obstacles to patent licensing. PIPX